Navigation Links
Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Date:8/15/2013

WOODCLIFF LAKE, N.J., Aug. 15, 2013 /PRNewswire/ -- Eisai Inc. announced today the launch of a new website to provide employers with an educational resource for information about obesity management. The website, "Closing the Gap: Obesity Management for Employers," can be accessed at http://ctgobesity.com/.

"We know from our research that most employers consider obesity to be a top employee health challenge," said Dave Martin, Vice President of Managed Markets, Value and Access for Eisai.  "While there are some helpful resources available for employers, we also noted significant gaps; therefore, we decided to build this all-inclusive website as a companion to an e-newsletter, in partnership with The Benfield Group."

Both the e-newsletter and the website will provide employers access to articles, links to other sites and other downloadable tools including:Closing the Gap in Obesity Management Solutions: The Importance of Integrating New Prescription Medications into Employer Strategies to Help Reduce Obesity in their Employee and Dependent Populations. A publication that reviews the challenges and opportunities of obesity management and provides recommendations from an Eisai-sponsored advisory board of leading employer health benefit decision-makers on approaches to update employer strategies.

Blueprint for Health™: A free, interactive online tool available through the American College of Occupational and Environmental Medicine (ACOEM) that allows employers to estimate direct and indirect costs associated with the conditions they select, by entering key employee demographics.

Your Weight Matters(SM) Campaign (YWM): The Your Weight Matters Campaign was developed by the Obesity Action Coalition (OAC) and sponsored
'/>"/>

SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
2. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
3. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
4. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
5. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
6. FDA Grants Orphan Drug Status To Eisais Lenvatinib
7. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
8. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
9. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Calif. , June 29, 2015 /PRNewswire/ ... of advanced visual prosthetic devices for the ... announced the publication of "Long-Term (60-month) Results ... Safety Outcomes Stratified by Age in Patients ... Clinical Ophthalmology . The 5-year data show ...
(Date:6/29/2015)... 29, 2015 /PRNewswire/-- CytRx Corporation (NASDAQ: CYTR ), ... today announced the presentation of interim results from its ... and safety of aldoxorubicin for the treatment of Kaposi,s ... presented on Wednesday, July 1, 2015 during a poster ... Herpesvirus (KSHV) and Related Agents in Hollywood, ...
(Date:6/29/2015)... , June 29, 2015  The automotive ... features to cars on the basis of consumer ... industry is now on the verge of integrating ... While automotive HWW non-critical features such as reconfigurable ... present in 30 to 40 percent of all ...
Breaking Medicine Technology:Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 2CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 3CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 4CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 5CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma 6Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Ouchless ® Needle by BellaNovus Development Company ... Dr. Mariano Busso is the latest in a growing ... its use for cosmetic injections. Dr. Busso is on ... localized pain resulting from cosmetic injections. Ouchless ® ...
... a critical care company focused on developing and commercializing ... the U.S. Food and Drug Administration (FDA) has granted ... oxide (iNO) with the INOpulse® DS drug-delivery system as ... investigational new drug application (IND) for PAH was submitted ...
Cached Medicine Technology:New Ouchless® Needle Collection Announces Leading Dermatology Testimonial 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 3FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 4
(Date:6/29/2015)... ... June 29, 2015 , ... Displays and Exhibits , a ... offering discounted pricing on all purchases that include branding. Enter price code brand2015 for ... the logo. The website, packaging and promotional materials, all should integrate the company logo ...
(Date:6/29/2015)... ... June 29, 2015 , ... Brittenford Systems, ... schools, and other growing businesses across the United States, has announced that it ... for the fifth consecutive year. , Based on company revenue and number of ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... Medical Devices , **FDAnews Webinar**, July 16, 2015 — 1:30 p.m. – 3:00 ... ensure the application of human factors engineering to the design of new products ...
(Date:6/29/2015)... ... 2015 , ... People across the country give their coworkers and families gifts all the time. ... , But, how often do coworkers donate “life” to the husband of a coworker? For ... , “Dawna (Wright-Thompson) told me her husband was on a donor list,” Glenshaw resident Kathi ...
(Date:6/29/2015)... ... June 29, 2015 , ... Two multicounty ... C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New Jersey’s ... Conference is to be convened on Thursday, July 23rd at 12:00 p.m. (In ...
Breaking Medicine News(10 mins):Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4
... Researchers comparing brain changes leading to dementia in people ... report initial results in a recent issue of Neurology.,// ... of all people with Down syndrome will eventually develop ... with Down syndrome show signs of the brain tangles ...
... significantly reduce the spread of the genital herpes virus.,Researchers ... one partner was diagnosed with //type 2 herpes and ... herpes causes a chronic genital viral infection and is ... given either 500 milligrams of valacyclovir once a day ...
... may do less harm than the X-rays used to diagnose the ... to have a significant effect on// how children with minor head ... of radiation can impair intellectual development. , ,The doses ... sometimes be done to check if there is any damage after ...
... twins, researchers conducted telephone interviews with 1,213 sets of ... to better understand the hereditary and environmental effects on ... but by interviewing the twins’ children (ages 12 to ... ,Although there is little question in the medical community ...
... suicide rates among more than 5 million service men and ... aimed at reducing an alarmingly high rate of suicide seen ... suicide rate had been particularly higher for black and white ... key components of the ongoing program are to provide support ...
... 20 percent to 30 percent of students are regularly ... as those attacked by bullies. In some cases, children ... and are victims of bullies. In all cases, these ... aren’t involved in bullying. However, most studies have relied ...
Cached Medicine News:Health News:Dementia and Down Syndrome 2Health News:Head injury X-rays may actually be causing harm, 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: